U2AF1 mutation variants in myelodysplastic syndromes and their clinical correlates

Mutations and prognosis in myelodysplastic syndromes: karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model

(2018) Naseema Gangat et al.   AMERICAN JOURNAL OF HEMATOLOGY

U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions

(2018) Ayalew Tefferi et al.   LEUKEMIA

Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromes

(2017) Bing Li et al.   GENES CHROMOSOMES & CANCER

Erratum: Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations

(2016) D Barraco et al.   Blood Cancer Journal

Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression

(2013) Shang-Ju Wu et al.   AMERICAN JOURNAL OF HEMATOLOGY

U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype

(2013) A Tefferi et al.   LEUKEMIA

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

(2012) P. L. Greenberg et al.   BLOOD

Frequent pathway mutations of splicing machinery in myelodysplasia

(2011) Kenichi Yoshida et al.   NATURE

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

(2009) J. W. Vardiman et al.   BLOOD